Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

SOP for External Audits

Posted on By

SOP for External Audits

Standard Operating Procedure for External Audits

1) Purpose

The purpose of this SOP is to define the procedure for preparing, conducting, and managing external audits conducted by regulatory authorities or external auditors to ensure compliance with regulatory requirements and quality standards.

2) Scope

This SOP applies to all departments and processes within the pharmaceutical manufacturing facility subject to external audits.

3) Responsibilities

3.1 Quality Assurance (QA) Manager
– Coordinate and facilitate external audits.
– Ensure readiness of the facility and personnel for audits.
3.2 Department Heads
– Cooperate with auditors during audits and provide necessary documentation and information.
3.3 Regulatory Affairs
– Serve as the primary contact for regulatory auditors.
– Ensure compliance with regulatory requirements and facilitate audit responses.

See also  SOP for Handling and Disposal of Waste Materials from FFS Machine

4) Procedure

4.1 Audit Notification
4.1.1 Receive notification of upcoming external audit from regulatory authorities or external auditors.
4.1.2 Inform relevant departments and personnel about the audit schedule and requirements.
4.2 Pre-Audit Preparation
4.2.1 Review previous audit reports and address any outstanding audit findings.
4.2.2 Conduct internal pre-audit activities, including mock audits, to assess readiness.
4.3 Audit Execution
4.3.1 Provide auditors with access to facilities, documents, and personnel as required.
4.3.2 Accompany auditors during facility tours and provide explanations as needed.
4.4 Audit Response
4.4.1

Document audit findings, observations, and any corrective actions required.
4.4.2 Prepare responses to audit findings and submit them within specified timelines.
4.5 Follow-Up Actions
4.5.1 Implement corrective actions as directed based on audit findings and recommendations.
4.5.2 Monitor and track the implementation and effectiveness of corrective actions.

See also  SOP for Control of Non-Conforming Materials

5) Abbreviations, if any

– QA: Quality Assurance

6) Documents, if any

– Audit Notification
– Audit Reports (External)
– Audit Response Plans

7) Reference, if any

– FDA Guidance for Industry: Quality Systems Approach to Pharmaceutical CGMP Regulations
– ICH Q7 Good Manufacturing Practice Guide for Active Pharmaceutical Ingredients

8) SOP Version

Version 1.0

Injectables Tags:Analytical method validation for injections, Aseptic media fill trials SOP, Bioburden testing for injections, Cleaning validation for injection equipment, Emulsion stability testing for injections, Formulation development for injections, Homogeneity testing for injections, IM injection SOP, Injection filling volume accuracy, Injection stability testing, Intramuscular injection procedure, Intravenous injection guidelines, IV injection SOP, Needle assembly for syringes SOP, Packaging integrity testing for injections, Particle size analysis for injections, Pre-filled syringe stability testing, Product sterility in aseptic processing, Reconstitution testing for injections, SC injection SOP, Subcutaneous injection technique, Syringe filling and capping SOP, Syringe labeling and inspection SOP, Temperature mapping in storage areas, Viscosity testing for injections

Post navigation

Previous Post: Purchase Departments: SOP for Handling of Expired Materials
Next Post: SOP for Hardness Testing of Tablets

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version